Respiratory medicines for children: current evidence, unlicensed use and research priorities
Smyth A. R., Barbato A., Beydon N., Bisgaard H., de Boeck K., Brand P., Bush A., Fauroux B., de Jongste J., Korppi M., O'Callaghan C., Pijnenburg M., Ratjen F., Southern K., Spencer D., Thomson A., Vyas H., Warris A., Merkus P. J.
Source: Eur Respir J 2010; 35: 247-265
Disease area: Paediatric lung diseases, Respiratory infections
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Smyth A. R., Barbato A., Beydon N., Bisgaard H., de Boeck K., Brand P., Bush A., Fauroux B., de Jongste J., Korppi M., O'Callaghan C., Pijnenburg M., Ratjen F., Southern K., Spencer D., Thomson A., Vyas H., Warris A., Merkus P. J.. Respiratory medicines for children: current evidence, unlicensed use and research priorities. Eur Respir J 2010; 35: 247-265
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: